Trinity Biotech plc (TRIB)

Trinity Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-36.48	-31.79	-24.02	-41.01	0.88
Depreciation & Amortization	2.32	1.87	1.78	2.33	2.74
Stock-Based Compensation	0.62	1.32	2.07	1.76	1.1
Other Adjustments	20.28	19.33	11	37.68	12.66
Change in Receivables	-	-2.37	1.05	-0.97	6.24
Changes in Inventories	-	-1.74	-0.97	-0.88	-4.41
Changes in Accounts Payable	-	8.19	-2.77	0.18	-7.59
Changes in Income Taxes Payable	-0.25	1.01	0.31	-0.02	1.62
Changes in Other Operating Activities	8.66	-	-	-	-
Operating Cash Flow	-4.86	-4.19	-11.56	-0.92	13.24
Capital Expenditures	-0.36	-0.41	-0.8	-1.1	-1.81
Purchases of Intangible Assets	-9.02	-9.66	-1.9	-4.88	-6.88
Purchases of Investments	-	-	-0.7	-	-
Payments for Business Acquisitions	-0.4	-12.9	-	-	-
Proceeds from Business Divestments	-	-	28.16	-	-
Investing Cash Flow	-9.79	-22.97	24.76	-5.98	-8.69
Long-Term Debt Issued	8	30.18	5	100.02	1.76
Long-Term Debt Repaid	-	-	-10.05	-121.25	-
Net Long-Term Debt Issued (Repaid)	8	30.18	-5.05	-21.24	1.76
Issuance of Common Stock	8.21	7.39	-	25.4	-
Net Common Stock Issued (Repurchased)	8.21	7.39	-	25.4	-
Other Financing Activities	-5.3	-8.76	-10.99	-16.48	-7.78
Financing Cash Flow	10.91	28.81	-16.04	-12.32	-6.02
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.03	-0.18	-0.04	-0.11	0.06
Net Cash Flow	-3.74	1.65	-2.84	-19.22	-1.47
Free Cash Flow	-5.22	-4.6	-12.36	-2.02	11.43
FCF Margin	-10.57%	-7.47%	-21.75%	-3.23%	14.08%
Free Cash Flow Per Share	-0.34	-0.26	-1.61	-0.30	2.73
Levered Free Cash Flow	-18.11	7.3	-31.52	-61.73	-6.81
Unlevered Free Cash Flow	-14.33	-12.59	-29.46	-18.74	-5.66

Updated Dec 23, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q